UPClytics
ENDE
Sign inStart trial
View all cases

UPC CFI 439/2025

May 19, 2025·EP3175863 · VARIANTS OF C-TYPE NATRIURETIC PEPTIDE

Follow
Case details
Status
Case Closed (Withdrawn)
Action
Counterclaim for revocation
Category
Counterclaim for revocation
Parties
Claimants
Representatives
Respondents
Representatives
Division
Munich LD
Judges
Technology
  • Chemistry
    Biotechnology · Pharmaceuticals
  • Instruments
    Analysis of biological materials
Language
English
EPO Opposition
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Patent revokedMedian days to first decision
All UPC37% (34/91)124
Munich LDLockedLocked
Judge Matthias ZigannLockedLocked
Judge András KupeczLockedLocked
Judge Tobias PichlmaierLockedLocked
Judge Eric EnderlinLockedLocked

At the UPC: Ascendis Pharma Growth Disorders A/S (3 cases)·BioMarin Pharmaceutical Inc. (3 cases)

Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent

This dispute contains 2 other proceedings

UPC CFI 18/2025·UPC APP 13067/2025

Start a free trial to see how each one ended.

More cases: Munich LD·2025

Decisions
  • —
    infringement

    Summary: 2. The withdrawal of the infringement action by the Claimant and the counterclaim action by the Defendants, actions UPC_CFI_18/2025 and UPC_CFI_439/2025, respectively, are permitted. 3. The Proceedings are declared closed.

Documents
Show all 96 documents
Document titleDatePublic
Case closed2025-12-29Not public
Decision2025-12-29Public
Decision2025-12-29Not public
Decision2025-12-29Not public
Order2025-10-24Not public
Order2025-10-24Not public
EPO_Communication_check_Outcome2025-08-11Not public
Hearing-Dates2025-07-30Not public
scheduling - final2025-07-30Public
Hearing-Dates2025-07-30Not public